Biomedical Research

The Medical University of South Carolina (MUSC) is the premier biomedical research institution in South Carolina. Our success in receiving research funding reflects an enterprise of basic and clinical scientists internationally recognized for biomedical work in diseases such as cancer, stroke, health disparities, addiction sciences, inflammation and fibrosis, and digestive disease - just to name a few! All a direct result of recruiting top scientists with a strategic focus to serve the needs of the people of South Carolina.

From bench lab to patient bedside, we are committed to leading health innovation for the lives we touch. We invite you to explore these stories, engage with us, and get to know the scientists who are the heart of our research community dedicated to changing what's possible in healthcare through state of the art research and discovery!

Quick Links

Introducing: In Our DNA SC

MUSC is excited to launch In Our DNA SC, a large-scale, first-of-its-kind community health research project in South Carolina investigating how DNA impacts health, with a broader goal of learning how to offer more personalized health care to our community.

Tell me more!

Research Highlights

a group of people sitting in folding chairs grin and wave at the camera

News

Record Riders

891 riders and 105 teams raised more than $433,000 to make LOWVELO22 the biggest yet.

News

Cancer Research

MUSC Hollings Cancer Center is investing in its scientists' research, providing pilot grants to help projects to get started.

News

Bad Behavior Brake

MUSC researchers have discovered a neural circuit that can stop risky behaviors.

In the News

With 98-year-old Jimmy Carter in hospice for his final days, an expert on aging at MUSC is reflecting on the former president’s remarkably long life at a time of decreasing life expectancy in the United States.

Thomas Curran in front of Ashley River Tower at MUSC

An MUSC Hollings Cancer Center colorectal cancer doctor is one of only 12 physicians across the nation to have been selected to participate in the National Cancer Institute’s Early-stage Surgeon Scientist Program (ESSP).